Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | April 01, 2019 | April 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MOLINA HEALTHCARE, INC.
Report date April 01, 2019 · Filed April 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,092 |
Reported balance
After 2019-04-01 transaction · row 1
1 source rowRow 1 · 2019-04-01 · Grant · Acquired 155 · Balance 19,092 F1: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2019, the first day of the quarter, was $144.70. Mr. Fedak's term as a Director ends on May 8, 2019, and he is not standing for re-election; thus, his quarterly grant was prorated accordingly. F3: Represents the closing price of the Issuer's common stock on April 1, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director.
F2: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2019, the first day of the quarter, was $144.70. Mr. Fedak's term as a Director ends on May 8, 2019, and he is not standing for re-election; thus, his quarterly grant was prorated accordingly.
F3: Represents the closing price of the Issuer's common stock on April 1, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2019 Filed Apr 3, 2019 23:25 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 155 | $144.70 | $22,428.50 |
DisclosureSEC source: 0001179929-19-000071 · wf-form4_155433388819841.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,092 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2019, the first day of the quarter, was $144.70. Mr. Fedak's term as a Director ends on May 8, 2019, and he is not standing for re-election; thus, his quarterly grant was prorated accordingly. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2019. Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 00:37 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 473 | $116.22 | $54,972.06 |
DisclosureSEC source: 0001179929-19-000017 · wf-form4_154656220809971.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,937 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2019 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2018, of $116.22. Thus, the grant this quarter for services as a Director is for 473 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2018. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:51 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,795 | $120.74 | $458,224.62 |
DisclosureSEC source: 0001179929-18-000197 · wf-form4_154283705277638.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,464 F1 · price: Represents the weighted average selling price per share with a selling price range between $119.8567 to $121.2100. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 23:55 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 371 | $148.14 | $54,959.94 |
DisclosureSEC source: 0001179929-18-000179 · wf-form4_153861092124770.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,259 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2018, the first day of the quarter, was $148.14, which resulted in a grant of 371 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2018. Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 23:00 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 562 | $97.94 | $55,042.28 |
DisclosureSEC source: 0001179929-18-000130 · wf-form4_153065884203547.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,888 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2018-2019 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 29, 2018, of $97.94. Thus, the grant this quarter for services as a Director is for 562 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 29, 2018. Read SEC document |
| April 01, 2018 Filed Apr 4, 2018 00:15 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 678 | $81.18 | $55,040.04 |
DisclosureSEC source: 0001179929-18-000087 · wf-form4_152280087930338.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,326 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 29, 2018, of $81.18. Thus, the grant this quarter for services as a Director is for 678 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 29, 2018. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 00:13 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,487 | $72.55 | $325,531.85 |
DisclosureSEC source: 0001179929-18-000035 · wf-form4_151882640215848.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,648 F1 · price: Represents the actual selling price for all 4,487 shares. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 01:10 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 717 | $76.68 | $54,979.56 |
DisclosureSEC source: 0001179929-18-000013 · wf-form4_151494181834450.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,135 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2017, of $76.68. Thus, the grant this quarter for services as a Director is for 717 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2017. Read SEC document |
| November 09, 2017 Filed Nov 10, 2017 00:13 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 7,493 | $76.50 | $573,214.50 |
DisclosureSEC source: 0001179929-17-000229 · wf-form4_151027278150915.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,418 F1 · price: Represents the weighted average selling price with a selling price range between $76.15 to $76.81. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 22:31 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 800 | $68.76 | $55,008.00 |
DisclosureSEC source: 0001179929-17-000197 · wf-form4_150698350094910.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,911 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2017, of $68.76. Thus, the grant this quarter for services as a Director is for 800 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:48 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000155 · wf-form4_149929130515502.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,111 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:57 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 1,206 | $45.60 | $54,993.60 |
DisclosureSEC source: 0001179929-17-000088 · wf-form4_149133944761361.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,316 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan in connection with the Reporting Person's services as a Director F2 · shares: The aggregate dollar value of the annual equity award to each director in 2016-2017 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2017, of $45.60. Thus, the grant this quarter for services as a director is for 1,206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2017. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 00:52 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 1,014 | $54.26 | $55,019.64 |
DisclosureSEC source: 0001179929-17-000016 · wf-form4_148349116054829.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,110 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan in connection with the Reporting Person's services as a Director F2 · shares: The aggregate dollar value of the annual equity award to each director in 2016-2017 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2016, of $54.26. Thus, the grant this quarter for services as a director is for 1,014 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2016. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 02:09 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,875 | $53.06 | $258,653.36 |
DisclosureSEC source: 0001179929-16-000405 · wf-form4_148055813315526.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F1 · price: Represents the weighted average selling price with a selling price range between $52.85 and $53.35. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 00:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 943 | $58.32 | $54,995.76 |
DisclosureSEC source: 0001179929-16-000382 · wf-form4_147554040911093.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,971 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan in connection with the Reporting Person's services as a director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2016-2017 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2016 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 30, 2016, of $58.32. Thus, the grant this quarter for services as a director is for 943 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 30, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.